Recursion biotech market cap
WebApr 16, 2024 · SALT LAKE CITY, April 16, 2024 /PRNewswire/ -- Recursion Pharmaceuticals, Inc. ("Recursion" or "we") today announced the pricing of its initial public offering of its … WebRecursion Pharmaceuticals ramped up its IPO target from $100 million to $306 million earlier this week, but the artificial intelligence biotech is scratching that plan.
Recursion biotech market cap
Did you know?
WebA list of the biggest publicly traded biotechnology companies, ranked by market cap. WebAll financial data provided by Standard & Poor's Capital IQ. Data Last Updated (UTC time) Company Analysis: 2024/03/19 00:00: End of Day Share Price
WebSalt Lake City, April 03, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery, today... Find the latest Recursion Pharmaceuticals, Inc. (RXRX) stock discussion in Yahoo … As of 02:57PM EDT. Market open. Salt Lake City, April 03, 2024 (GLOBE NEWSWIRE) - … Recursion Pharmaceuticals, Inc. 41 South Rio Grande Street Salt Lake City, UT … See Recursion Pharmaceuticals, Inc. (RXRX) stock analyst estimates, including … Find out all the key statistics for Recursion Pharmaceuticals, Inc. (RXRX), including … Get the detailed quarterly/annual income statement for Recursion … View the basic RXRX option chain and compare options of Recursion … See Recursion Pharmaceuticals, Inc. (RXRX) Environment, Social and Governance … Find the latest Recursion Pharmaceuticals, Inc. (RXRX) stock quote, history, news … SALT LAKE CITY, March 01, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: …
WebAs of March 2024 Recursion Pharmaceuticals has a market cap of $1.29 Billion . This makes Recursion Pharmaceuticals the world's 4303th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly … WebApr 27, 2024 · So far, the company is off to a running start. After ending its IPO on April 20, Recursion is sitting pretty on $501.8 million in gross proceeds. That's more than enough …
WebApr 16, 2024 · Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the …
WebRecursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral ... eco piscine d\u0027objatWebJun 30, 2024 · These indices determine membership primarily by objective, market-capitalization rankings and style attributes. About Recursion Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, machine learning, and engineering. tbhk rankingWebApr 10, 2024 · RXRX’s market cap is 1.25 Bil. Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. tbhk readWebMarket capitalization of Recursion Pharmaceuticals (RXRX) Market cap: $1.29 Billion As of March 2024 Recursion Pharmaceuticals has a market cap of $1.29 Billion . This makes … tbhk pfp mitsubaWebMarket Cap $1.58 B Shares Outstanding 181.69 M Public Float 123.15 M Yield RXRX is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend Date N/A Short … eco ninjatraderWebRecursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. tbhk remakeWebJul 2, 2024 · Before entering the public markets this spring, Recursion had attracted over $460 million in venture investments, according to tech data aggregator Crunchbase. At … eco escape kodaikanal